At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Oct 31, 2008 palling david Officer Automatic Sell 2,200 10.00
Oct 30, 2008 palling david Officer Automatic Sell 300 10.00
Sep 29, 2008 palling david Officer Automatic Sell 2,500 15.03 - 16.22
Sep 8, 2008 palling david Officer Sell 3,000 14.83
Aug 28, 2008 palling david Officer Automatic Sell 2,500 13.77
Jul 28, 2008 palling david Officer Automatic Sell 2,500 15.08
Apr 24, 2008 palling david Officer Option Execute 20,000 0.64
Apr 1, 2008 palling david Officer Automatic Sell 1,250 11.00 - 11.25
Feb 28, 2008 palling david Officer Sell 2,500 10.46 - 10.55
Feb 1, 2008 palling david Officer Sell 3,000 10.00
May 30, 2007 palling david Officer Statement of Ownership 0 n/a
May 30, 2007 palling david Officer Statement of Ownership 0 n/a
Apr 18, 2011 patterson matthew r Officer Acquisition (Non Open Market) 50,000 n/a
Dec 2, 2008 patterson matthew r Officer Option Execute 20,098 0.64
Oct 31, 2008 patterson matthew r Officer Automatic Sell 1,939 10.00
Oct 30, 2008 patterson matthew r Officer Automatic Sell 361 10.00
Oct 23, 2008 patterson matthew r Officer Automatic Sell 100 10.10
Oct 22, 2008 patterson matthew r Officer Automatic Sell 3,100 10.40
Oct 21, 2008 patterson matthew r Officer Automatic Sell 2,500 10.51
Oct 20, 2008 patterson matthew r Officer Automatic Sell 2,000 10.73 - 11.51
Showing 281-300 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy